Cargando…
Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer
BACKGROUND: Triple-negative breast cancer (TNBC) is a highly aggressive cancer with poor prognosis. The lack of effective targeted therapies for TNBC remains a profound clinical challenge. Fusion transcripts play critical roles in carcinogenesis and serve as valuable diagnostic and therapeutic targe...
Autores principales: | Wang, Meng-Yuan, Huang, Man, Wang, Chao-Yi, Tang, Xiao-Ying, Wang, Jian-Gen, Yang, Yong-De, Xiong, Xin, Gao, Chao-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239224/ https://www.ncbi.nlm.nih.gov/pubmed/34211850 http://dx.doi.org/10.3389/fonc.2021.682021 |
Ejemplares similares
-
High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer
por: Liu, Xinkui, et al.
Publicado: (2021) -
Mfge8 attenuates human gastric antrum smooth muscle contractions
por: Li, Wen, et al.
Publicado: (2021) -
MFGE8 inhibits insulin signaling through PTP1B
por: Datta, Ritwik, et al.
Publicado: (2023) -
Dissecting Heterogeneity Reveals a Unique BAMBI(high)MFGE8(high) Subpopulation of Human UC‐MSCs
por: Chen, Hongwei, et al.
Publicado: (2022) -
Hapln2 in Neurological Diseases and Its Potential as Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2019)